TwitterLinkedin

Contact Us

  • News & Events
    • News
    • Press Releases
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Our Milestones
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical

          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistical Services
    • Clinical Development

          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistical Services

          • Regulatory Affairs

            • Clinical Trial Applications
            • Health Authority / Agency Interaction
            • Regulatory Operations

          • Pharmacovigilance

            • Clinical Trial Safety Support

          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval

          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistical Services

          • Pharmacovigilance

            • EU QPPV / National QPPV

          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
    • Post-approval / Maintenance

          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations

          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management

          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • Good Distribution Practice (GDP) Compliance
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems

          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management

          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise

          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services

          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • Brexit
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Statistical Services
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • News
    • Press Releases
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Career Opportunities
  • Training
Home > News & Events

News & Events

PharmaLex Brexit Services Q&A with our experts…

28th July 2021

Welcome to the team – Michael Makris

Welcome to the team – Michael Makris

28th July 2021

Signal Detection

Signal Detection

16th July 2021

Log or not log (transform data) that’s the question

Log or not log (transform data) that’s the question

1st July 2021

Data Science on Blockchain with R. Part I: Reading the blockchain

Data Science on Blockchain with R. Part I: Reading the blockchain

23rd June 2021

Bayesian Statistics: Model to predict recruitment and inform supply chain

Bayesian Statistics: Model to predict recruitment and inform supply chain

22nd June 2021

Enoval et les laboratoires accrédités

Enoval et les laboratoires accrédités

7th June 2021

PharmaLex broadens market access and HEOR reach

PharmaLex broadens market access and HEOR reach

4th June 2021

Resilience of Pharma Supply Chains and the Impact of Covid-19 Pandemic

Resilience of Pharma Supply Chains and the Impact of Covid-19 Pandemic

17th May 2021

PharmaLex expands APAC region

PharmaLex expands APAC region

23rd April 2021

Contamination Control

Contamination Control

8th April 2021

Rules on Ownership of Medicinal Product stock distributed in Great Britain

Rules on Ownership of Medicinal Product stock distributed in Great Britain

7th April 2021

GET SMART: reliable analytical results & continuous regulatory compliance!

GET SMART: reliable analytical results & continuous regulatory compliance!

30th March 2021

PharmaLex expands France BENELUX region

PharmaLex expands France BENELUX region

16th March 2021

Challenges of Advanced Therapy Medicinal Products (ATMPs)

Challenges of Advanced Therapy Medicinal Products (ATMPs)

16th March 2021

PharmaLex broadens biopharma expertise

PharmaLex broadens biopharma expertise

5th March 2021

Supporting M&A in the pharmaceutical / biopharmaceutical industry

Supporting M&A in the pharmaceutical / biopharmaceutical industry

11th February 2021

EU GMP Annex 1

EU GMP Annex 1

25th January 2021

New Partnership Announcement for MEPHARMA and PharmaLex

New Partnership Announcement for MEPHARMA and PharmaLex

21st January 2021

BIO International Convention 2021

BIO International Convention 2021

20th January 2021

DIA RSIDM 2021

DIA RSIDM 2021

20th January 2021

TOPRA Symposium 2021

TOPRA Symposium 2021

19th January 2021

DIA Annual Meeting 2021

DIA Annual Meeting 2021

19th January 2021

BIO Europe Spring 2021

BIO Europe Spring 2021

19th January 2021

DIA Europe 2021

DIA Europe 2021

19th January 2021

SMARTRISK – risk assessment excipient tool

SMARTRISK – risk assessment excipient tool

12th January 2021

Medical Devices in the Digital Health Era

Medical Devices in the Digital Health Era

10th December 2020

Medicinal Cannabis: The Wonder Substance

Medicinal Cannabis: The Wonder Substance

1st December 2020

Regulatory Challenges in the COVID Era

Regulatory Challenges in the COVID Era

1st December 2020

PharmaLex creates specialized biopharma service line

PharmaLex creates specialized biopharma service line

20th October 2020
Upcoming Events

September 22 - 24th, 2021

TOPRA Symposium 2021

Recent News
  • PharmaLex Brexit Services Q&A with our experts…
    28th July 2021
  • Welcome to the team – Michael Makris
    28th July 2021
  • PharmaLex Series “A day in the life of“
    27th July 2021
  • The development of COVID-19 vaccines has alerted the public
    27th July 2021
  • Awards – view the various awards we have won
    27th July 2021
  • Signal Detection
    16th July 2021
Categories
  • All News
  • Webinars
  • Events
Archive
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
Tweets by @PharmaLexGLOBAL
COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY

  • Hard working and there when you need them

    Europe based large biotech
    Regulatory Manager
PharmaLex
©2021 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit Logo

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.





    Select your state:

    .
    You can unsubscribe at any time at data.protection@pharmalex.com

    Click here to view our Privacy Policy.

    #AskTheExpert #TogetherBEYONDCOVID19





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #TogetherBEYONDCOVID19

      We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for